All Valeant articles

  • Blog post

    Tone at the top really does matter


    The Man From FCPA Tom Fox looks at the case of disgraced pharmaceutical company Valeant and what new Chief Financial Officer Paul Herendeen has planned for the company’s future.

  • Blog post

    Tone at the top and (former) CEO consulting


    What does retaining a disgraced CEO as a consultant tell you about tone at the top?

  • Blog post

    Where Valeant, and Corporate America, Went Wrong


    Image: The big political story this week was the Republican presidential debate, and candidates’ usual complaints that too many Americans are falling behind economically. The big corporate governance story, meanwhile, has been the unraveling of Valeant Pharmaceuticals. The two are tied, Compliance Week editor Matt Kelly writes—since Valeant’s misplaced corporate ...